{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:18:03Z","timestamp":1791011883657,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1053\/j.ajkd.2007.03.008","type":"journal-article","created":{"date-parts":[[2007,5,30]],"date-time":"2007-05-30T14:42:18Z","timestamp":1180536138000},"page":"814-823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Intravenous Paricalcitol for Treatment of Secondary Hyperparathyroidism in Children on Hemodialysis"],"prefix":"10.1053","volume":"49","author":[{"given":"Larry A.","family":"Greenbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Benador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel Z.","family":"Melnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Mattingly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Amdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro B.","family":"Salusky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2007.03.008_bib1","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem-67-5-876","article-title":"Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure","volume":"67","author":"Pitts","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.ajkd.2007.03.008_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0272-6386(12)80977-2","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"23","author":"Slatopolsky","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2007.03.008_bib3","first-page":"F432","article-title":"Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol","volume":"259","author":"Lopez","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1053\/j.ajkd.2007.03.008_bib4","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1523-1755.2001.0590031187.x","article-title":"Recent developments in the management of secondary hyperparathyroidism","volume":"59","author":"Goodman","year":"2001","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.03.008_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJM197802022980503","article-title":"Increased growth after long-term oral 1alpha,25-vitamin D3 in childhood renal osteodystrophy","volume":"298","author":"Chesney","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2007.03.008_bib6","first-page":"644","article-title":"Renal bone disorders in children: Therapy with vitamin D3 or 1,25-dihydroxycholecalciferol","volume":"16","author":"Bulla","year":"1979","journal-title":"Proc Eur Dial Transplant Assoc Eur Ren Assoc"},{"issue":"suppl","key":"10.1053\/j.ajkd.2007.03.008_bib7","first-page":"S109","article-title":"The effect of 1alpha-hydroxyvitamin D3 in pre-dialysis renal bone disease","volume":"7","author":"Pierides","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"suppl","key":"10.1053\/j.ajkd.2007.03.008_bib8","first-page":"S117","article-title":"Bone disease in children with chronic renal failure: Therapy with 1alpha-hydroxyvitamin D3","volume":"7","author":"Postlethwaite","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1053\/j.ajkd.2007.03.008_bib9","first-page":"E961","article-title":"Calcitriol therapy and calcium-regulated PTH secretion in patients with secondary hyperparathyroidism","volume":"267","author":"Ramirez","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1053\/j.ajkd.2007.03.008_bib10","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI111639","article-title":"Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients","volume":"74","author":"Slatopolsky","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2007.03.008_bib11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0272-6386(12)80831-6","article-title":"Safety and efficacy of long-term treatment of secondary hyperparathyroidism by low-dose intravenous calcitriol","volume":"19","author":"Sprague","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2007.03.008_bib12","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00467-004-1792-6","article-title":"Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis","volume":"20","author":"Greenbaum","year":"2005","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.ajkd.2007.03.008_bib13","series-title":"North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) Annual Report","author":"Ho","year":"2002"},{"key":"10.1053\/j.ajkd.2007.03.008_bib14","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI114022","article-title":"Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D","volume":"83","author":"Delmez","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2007.03.008_bib15","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI112714","article-title":"Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat","volume":"78","author":"Silver","year":"1986","journal-title":"J Clin Invest"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2007.03.008_bib16","first-page":"S1","article-title":"K\/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2007.03.008_bib17","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1523-1755.1998.00045.x","article-title":"Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration","volume":"54","author":"Salusky","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.03.008_bib18","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2007.03.008_bib19","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2007.03.008_bib20","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ki.1990.293","article-title":"Soft tissue calcification in pediatric patients with end-stage renal disease","volume":"38","author":"Milliner","year":"1990","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.03.008_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","article-title":"Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure","volume":"106","author":"Oh","year":"2002","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2007.03.008_bib22","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.03.008_bib23","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1046\/j.1523-1755.2003.00878.x","article-title":"Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism","volume":"63","author":"Sprague","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.03.008_bib24","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1-alpha-25-dihydroxyvitamin D2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.03.008_bib25","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin Chem"},{"key":"10.1053\/j.ajkd.2007.03.008_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ki.1994.31","article-title":"Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD\/CCPD","volume":"45","author":"Salusky","year":"1994","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.03.008_bib27","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1046\/j.1523-1755.2003.00915.x","article-title":"Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis","volume":"63","author":"Salusky","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.03.008_bib28","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0031-3955(16)40097-0","article-title":"Bone and mineral metabolism in childhood end-stage renal disease","volume":"42","author":"Salusky","year":"1995","journal-title":"Pediatr Clin North Am"},{"key":"10.1053\/j.ajkd.2007.03.008_bib29","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1111\/j.1523-1755.2004.66015.x","article-title":"Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro","volume":"66","author":"Yang","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.03.008_bib30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.2002.00472.x","article-title":"Cardiovascular disease in pediatric chronic dialysis patients","volume":"62","author":"Chavers","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.03.008_bib31","first-page":"315","article-title":"A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease","volume":"56","author":"Lindberg","year":"2001","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2007.03.008_bib32","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1681\/ASN.2004100885","article-title":"Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols","volume":"16","author":"Salusky","year":"2005","journal-title":"J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638607006403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638607006403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:47:32Z","timestamp":1759456052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638607006403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0272638607006403"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2007.03.008","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Paricalcitol for Treatment of Secondary Hyperparathyroidism in Children on Hemodialysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2007.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}